Ledger.Open graph →
SEC Form D · filed August 31, 2015

Aprecia Pharmaceuticals Co

Offering
$52.0M
Sold
$38.8M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
LANGHORNE, PA
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (18)

James T. Evans · Cincinnati, OHDirectorEtienne T. Perold · Pennington, NJDirectorPhilip Cater · George Town, Grand Cayman, Cayman IslandsDirectorCato Partners GP, LLC · New York, NYDirectorE T. Arington · Mason, OHDirectorDonald T. Wetherhold · Loveland, OHExecMichael T. Rohlfs · West Chester, OHExecLawrence T. Glassmann · Cincinnati, OHDirectorDavid T. Furniss · Mason, OHExecRobert T. Williford · Cincinnati, OHExecPeter S. Grosskopf · Toronto, Ontario, CanadaDirectorArthur R. Rule, Iv · Toronto, Ontario, CanadaDirectorE T. Arington · Mason, OHDirectorDonald T. Wetherhold · Loveland, OHExecMichael T. Rohlfs · West Chester, OHExecLawrence T. Glassmann · Cincinnati, OHDirectorDavid T. Furniss · Mason, OHExecRobert T. Williford · Cincinnati, OHExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗